Consulting
Q&A – Racial Diversity in Clinical Trials: Building Trust in Participant Engagement
Our experts answered some of the most popular questions from "Racial Diversity in Clinical Trials: Building Trust in Participant Engagement."
Takeaways From the FDA’s VRBPAC Meeting – October 22, 2020
On October 22, 2020, the FDA's VRBPAC met to discuss the development, authorization, and licensure of vaccines to prevent COVID-19.
By the Numbers: Our Response to COVID-19
See the data points in our infograhpic to find out how Advarra helps keep research moving forward.
How Medicare’s New Imaging Program Affects Clinical Trials in Oncology
Billing compliance is an essential part of clinical trial participation, and this is especially important for high-cost services such as CT scans, PET scans, nuclear medicine, and MRIs. However, organizations ...
Beginner’s Guide to Investigator-Initiated Trials
In investigator-initiated trials, an investigator takes on the clinical study as both the sponsor and investigator. Learn more about IITs impact on the clinical research industry.
5 Tips for Successful Project Management in Clinical Research
Learn how to improve project management practices at your clinical research organization and reduce the risk of complications on clinical trials.
Is GDPR Coming to the US? CCPA and Its Impact on Research
New California regulations apply to companies who have information about CA residents regardless of where the company is located. Read more:
Research Staffing Strategies During Challenging Times
With hiring freezes, furloughs, in-person restrictions, and changes in workflows and documentation, the COVID-19 pandemic has had a significant effect on clinical research staffing. What will it look like when ...
Q&A – The Must-Haves of FDA and Common Rule Reporting Requirements
Find out more about what to report to whom--and when--in the Q&A blog follow-up to our recent webinar. Read the answers to popular audience questions:
Racial Diversity in Clinical Trials: Building Trust in Participant Engagement
COVID-19 has focused the importance of diversity, equity, and inclusion considerations in clinical trial enrollment. How can the research community address the root causes for lack of diversity? What actions ...
3 Essential Elements of Change Management Within Clinical Research Operations At Your Research Site
Learn how to make sure the three critical factors for productive change are equally balanced considerations of your change management efforts.
Getting “Engaged” in the Time of COVID
When using remote sites to perform clinical trial procedures, keep in mind things like whether remote sites are considered "engaged" in research. Read more: